Statements (15)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
gptkbp:CASNumber |
681152-60-7
|
gptkbp:clinicalTrialPhase |
Phase III (failed)
|
gptkbp:developedBy |
gptkb:Alzheimer's_disease
|
gptkbp:developer |
gptkb:Axovant_Sciences
|
gptkbp:hasMolecularFormula |
C23H28F3N3O
|
https://www.w3.org/2000/01/rdf-schema#label |
intepirdine
|
gptkbp:IUPACName |
3-(2,2,2-trifluoro-1-methyl-1H-indol-3-yl)-N-(piperidin-1-yl)propanamide
|
gptkbp:mechanismOfAction |
5-HT6 receptor antagonist
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:status |
development discontinued
|
gptkbp:synonym |
SB-742457
|
gptkbp:bfsParent |
gptkb:Axovant_Sciences
|
gptkbp:bfsLayer |
7
|